Login to Your Account

Genetic Model Company GenPath Raises $42.7M In Series B Round

By Kim Coghill

Friday, October 3, 2003
Little more than a year after starting a business based on spontaneous tumor models in mice, GenPath Pharmaceuticals Inc. raised $42.7 million in a Series B financing. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription